Company: REVB
Filing Date: 2025-11-12
Form Type: S-8
Source: 0001193125-25-277581
Chunk: 0

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: S-8
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 REVELATION BIOSCIENCES, INC. (Exact name of registrant as specified in its charter)

| Delaware                        |     | 84-3898466         |
| (State or other jurisdiction of 
 incorporation or organization)  |     | -I.R.S. Employer   
 Identification No. |

4660 La Jolla Village Drive, Suite 100 San Diego, CA 92122 (Address of principal executive offices, including zip code) REVELATION BIOSCIENCES, INC. 2021 EQUITY INCENTIVE PLAN (Full title of the plan) James Rolke, Chief Executive Officer Revelation Biosciences, Inc. 4660 La Jolla Village Drive, Suite 100 San Diego, CA 92122 650-800-3717 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Stephen M. Cohen, Esq.
Lauren W. Taylor, Esq.
Fox Rothschild LLP 2001 Market Street, Suite 1700 Philadelphia, PA 19103 Telephone: 215-299-2000 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large accelerated filer ☐ | Accelerated filer ☐         |
| Non-accelerated filer ☒   | Smaller Reporting Company ☒ |
|                           | Emerging growth company ☐   |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

<div align='center'>PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>

Item 1. Plan Information

This Registration Statement is being filed for the purpose of registering 4,647,222 additional shares of common stock, par value $0.001 (“Common Stock”), of Revelation Biosciences,